Understanding Melasma: Causes, Triggers, and Treatment Options

What Is Melasma

Melasma is a chronic hyperpigmentation condition where melanocytes (the cells that produce pigment) become overactive in specific areas, producing excess melanin. It presents as brown or grey-brown patches, typically on the cheeks, forehead, bridge of the nose, upper lip, and chin. The patches are usually symmetrical, appearing on both sides of the face in a mirrored pattern.

Melasma affects over 5 million people in North America, with women accounting for approximately 90 percent of cases. It is not dangerous and has no physical symptoms, but it can significantly affect quality of life and self-confidence.

Why Melanocytes Overproduce: The Biology

The mechanism behind melasma is more complex than simple sun damage. Several overlapping biological pathways drive melanocyte overactivity:

Hormonal Stimulation

Hormones are the most significant driver. Estrogen and progesterone directly stimulate melanocyte activity, which is why melasma disproportionately affects women during:

• Pregnancy: So common during pregnancy that melasma has been called "the mask of pregnancy." The hormonal surge activates melanocytes, particularly in sun-exposed facial skin.
• Oral contraceptive use: The combination of estrogen and progesterone in hormonal birth control replicates the hormonal trigger of pregnancy-related melasma.
• Hormone replacement therapy: Estrogen supplementation during menopause can trigger or worsen existing melasma.

UV Radiation

UV exposure is both a cause and the primary ongoing trigger. UV light stimulates melanocytes directly through two pathways: it activates the tyrosinase enzyme (which catalyzes melanin production) and it triggers inflammatory mediators that signal melanocytes to produce more pigment.

This dual mechanism explains why even small amounts of unprotected sun exposure can trigger a melasma flare-up that undoes weeks of treatment progress.

Visible Light and Heat

Recent research has demonstrated that visible light (particularly the blue-violet spectrum, 400-500nm) and infrared heat can also stimulate melanocytes in melasma-prone skin. This is clinically significant because most conventional sunscreens only block UV radiation. A person who is diligent about sunscreen application but uses a clear (non-tinted) formula may still experience flare-ups from visible light exposure.

Genetic Predisposition

Melasma clusters in families and is more prevalent in individuals with darker skin tones (Fitzpatrick III-VI), including those of Latin American, South Asian, Middle Eastern, and Mediterranean descent. The genetic component means that some people's melanocytes are inherently more responsive to hormonal and UV triggers.

Types of Melasma: Depth Determines Treatment Response

Melasma is classified by where the excess melanin sits in the skin, which directly affects how it responds to treatment:

• Epidermal melasma: Pigment sits in the upper skin layer. Appears brown with well-defined borders. Responds best to topical treatments and superficial peels because the target is accessible from the surface.
• Dermal melasma: Pigment sits deeper in the dermis, trapped in macrophages and scattered among collagen fibres. Appears grey or blue-grey. Significantly more difficult to treat because topical agents cannot easily reach the deep pigment.
• Mixed melasma: A combination of both. The most common type. Shows brown and grey-brown patches of varying depth.

A Wood's lamp examination can help distinguish the type. Under UV light, epidermal pigment becomes more visible while dermal pigment does not fluoresce. This assessment guides treatment selection.

Treatment Approach at IVONNE

Melasma is a chronic condition. There is no permanent cure. The goal is management: reducing visible pigmentation, preventing flare-ups, and maintaining results through ongoing care. Effective management requires a multi-pronged approach because no single treatment addresses all the pathways involved.

Topical Agents: The Foundation

AlumierMD offers several products relevant to melasma management:

• Intellibright Complex: A multi-pathway brightening serum that targets tyrosinase activity (the enzyme that catalyzes melanin production) through multiple inhibitors rather than a single agent. Multi-pathway inhibition is more effective than single-agent approaches because melanocytes can develop resistance to individual inhibitors.
• EvenTone: Targeted spot treatment for localized areas of hyperpigmentation.
• Retinol Resurfacing Serum (0.25/0.5/1.0): Accelerates cell turnover, which helps shed pigmented cells faster. Must be introduced gradually and used at the lowest effective concentration, particularly in melasma-prone skin where irritation can trigger more pigment production (post-inflammatory hyperpigmentation).
• EverActive C&E + Peptide: Vitamin C is an antioxidant that also inhibits tyrosinase. The EverActive delivery system activates fresh vitamin C at the time of use, avoiding the oxidation problem that degrades vitamin C in pre-mixed serums.

AlumierMD Glow Peel

The Glow Peel is particularly relevant for melasma because it combines lactic acid (AHA exfoliation), salicylic acid (BHA penetration), and resorcinol (a tyrosinase inhibitor). This triple-action approach exfoliates pigmented epidermal cells while simultaneously suppressing new melanin production.

The peel depth is carefully controlled. Aggressive peels are contraindicated in melasma because the inflammation from a deep peel can trigger a rebound flare of pigmentation that is worse than the original condition. The Glow Peel is calibrated to correct without over-treating.

Microneedling

Microneedling creates controlled micro-channels in the skin using an elite micropen device with up to 12 clinical-grade pins. For melasma, the primary benefit is enhanced delivery of topical lightening agents through these micro-channels. The needle depth is kept conservative to avoid triggering the inflammatory cascade that worsens pigmentation.

At IVONNE, microneedling is combined with AnteAGE next-generation cytokine serum containing growth factors that support healing and skin remodeling. This combination improves texture while the enhanced delivery of post-treatment brightening agents works on the pigmentation.

What About Laser Treatment for Melasma?

Laser treatment for melasma requires extreme caution. While some laser modalities (particularly low-fluence Q-switched Nd:YAG) have shown benefit in studies, aggressive laser settings can trigger significant rebound hyperpigmentation in melasma-prone skin. The heat and inflammation from laser treatment stimulate the same melanocyte pathways that caused the melasma in the first place.

IVONNE's PicoWay laser uses picosecond pulses that generate less heat than nanosecond lasers, which theoretically reduces the inflammatory trigger. However, laser treatment for melasma is approached conservatively and only after other modalities have been tried. It is not a first-line treatment.

Sun Protection: The Non-Negotiable

No melasma treatment works without rigorous, daily sun protection. A single unprotected sun exposure can undo weeks of treatment progress by reactivating the melanocytes that treatment was suppressing.

Effective sun protection for melasma goes beyond standard sunscreen advice:

• Broad-spectrum SPF 30+ every morning, regardless of weather. UVA penetrates clouds and windows.
• Tinted mineral sunscreen with iron oxide to block visible light. AlumierMD's Sheer Hydration SPF 40 (Versatile Tint) or Moisture Matte SPF 40 (Ivory/Sand/Amber) provide both UV and visible light protection.
• Reapplication every 2 hours during extended outdoor exposure.
• Physical barriers: Wide-brimmed hat and sunglasses when outdoors.

Managing Expectations

Melasma responds to treatment, but it requires patience, consistency, and realistic expectations:

• 2 to 3 months of consistent treatment before noticeable improvement. Results are gradual.
• Recurrence is common. Hormonal changes, sun exposure, or discontinuation of maintenance products can reactivate melanocytes.
• Aggressive treatment backfires. The instinct to treat melasma aggressively (high-strength peels, aggressive laser) often triggers rebound hyperpigmentation. Gentle, consistent treatment over time is more effective.
• Maintenance is ongoing. Melasma is managed, not cured. Ongoing sun protection and maintenance products are part of the long-term commitment.